Randomized Study of Nivolumab+Ipilimumab+/- SBRT for Metastatic Merkel Cell Carcinoma
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Pfizer
Jules Bordet Institute
H. Lee Moffitt Cancer Center and Research Institute
Dana-Farber Cancer Institute
Regeneron Pharmaceuticals
Alliance for Clinical Trials in Oncology
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Massachusetts General Hospital
H. Lee Moffitt Cancer Center and Research Institute
Iovance Biotherapeutics, Inc.
Massachusetts General Hospital
National Institutes of Health Clinical Center (CC)
Melanoma Institute Australia
H. Lee Moffitt Cancer Center and Research Institute
National Institutes of Health Clinical Center (CC)
H. Lee Moffitt Cancer Center and Research Institute
British Columbia Cancer Agency
Memorial Sloan Kettering Cancer Center
Eastern Cooperative Oncology Group
Verrica Pharmaceuticals Inc.
Massachusetts General Hospital
Massachusetts General Hospital